相似文献
1
Carvedilol--NSBB of choice in all cirrhotics? Short title: Carvedilol for portal hypertension.
Saudi J Gastroenterol. 2015 Sep-Oct;21(5):265-6. doi: 10.4103/1319-3767.166204.
2
The 35-year odyssey of beta blockers in cirrhosis: any gender difference in sight?
Pharmacol Res. 2017 May;119:20-26. doi: 10.1016/j.phrs.2017.01.015. Epub 2017 Jan 15.
3
Acute administration of carvedilol is more effective than propranolol plus isosorbide-5-mononitrate in the reduction of portal pressure in patients with viral cirrhosis.
Am J Gastroenterol. 2004 Oct;99(10):1953-8. doi: 10.1111/j.1572-0241.2004.40179.x.
4
Carvedilol for portal hypertension in patients with cirrhosis.
Hepatology. 2010 Jun;51(6):2214-8. doi: 10.1002/hep.23689.
5
Randomized comparison of long-term carvedilol and propranolol administration in the treatment of portal hypertension in cirrhosis.
Hepatology. 2002 Dec;36(6):1367-73. doi: 10.1053/jhep.2002.36947.
6
Carvedilol, a new nonselective beta-blocker with intrinsic anti- Alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis.
Hepatology. 1999 Jul;30(1):79-83. doi: 10.1002/hep.510300124.
7
Acute and 14-day hepatic venous pressure gradient response to carvedilol and nebivolol in patients with liver cirrhosis.
Medicina (Kaunas). 2013;49(11):467-73.
8
The effects of carvedilol a nonselective beta-blocker on portal hemodynamics in cirrhosis.
Rom J Intern Med. 2003;41(3):247-54.
9
The portal hypertension syndrome: etiology, classification, relevance, and animal models.
Hepatol Int. 2018 Feb;12(Suppl 1):1-10. doi: 10.1007/s12072-017-9827-9. Epub 2017 Oct 24.
10
Differences in portal hemodynamics in cirrhosis and idiopathic portal hypertension.
Am J Gastroenterol. 1989 Apr;84(4):409-12.
引用本文的文献
1
CARVEDILOL AS PRIMARY PROPHYLAXIS FOR GASTRIC VARICEAL BLEEDING IN PORTAL HYPERTENSION MODEL IN RATS.
Arq Bras Cir Dig. 2020 Dec 16;33(3):e1525. doi: 10.1590/0102-672020200003e1525. eCollection 2020.
本文引用的文献
1
The effect of carvedilol and propranolol on portal hypertension in patients with cirrhosis: a meta-analysis.
Patient Prefer Adherence. 2015 Jul 14;9:961-70. doi: 10.2147/PPA.S84762. eCollection 2015.
2
Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension.
J Hepatol. 2015 Sep;63(3):743-52. doi: 10.1016/j.jhep.2015.05.022. Epub 2015 Jun 3.
3
Multicentre randomised controlled study comparing carvedilol with variceal band ligation in the prevention of variceal rebleeding.
J Hepatol. 2014 Nov;61(5):1014-9. doi: 10.1016/j.jhep.2014.06.015. Epub 2014 Jun 19.
4
Carvedilol vs. esophageal variceal band ligation in the primary prophylaxis of variceal hemorrhage: a multicentre randomized controlled trial.
J Hepatol. 2014 Apr;60(4):757-64. doi: 10.1016/j.jhep.2013.11.019. Epub 2013 Nov 28.
5
Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol.
Gut. 2013 Nov;62(11):1634-41. doi: 10.1136/gutjnl-2012-304038. Epub 2012 Dec 18.
6
Randomized, controlled trial of carvedilol versus nadolol plus isosorbide mononitrate for the prevention of variceal rebleeding.
J Gastroenterol Hepatol. 2012 Nov;27(11):1681-7. doi: 10.1111/j.1440-1746.2012.07244.x.
7
Carvedilol or propranolol in portal hypertension? A randomized comparison.
Scand J Gastroenterol. 2012 Apr;47(4):467-74. doi: 10.3109/00365521.2012.666673. Epub 2012 Mar 9.
8
The clinical use of HVPG measurements in chronic liver disease.
Nat Rev Gastroenterol Hepatol. 2009 Oct;6(10):573-82. doi: 10.1038/nrgastro.2009.149. Epub 2009 Sep 1.
9
Randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleed.
Hepatology. 2009 Sep;50(3):825-33. doi: 10.1002/hep.23045.
10
Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
Gastroenterology. 2007 Aug;133(2):481-8. doi: 10.1053/j.gastro.2007.05.024. Epub 2007 May 21.
Zotero 插件